Extended treatment with lamivudine and adefovir dipivoxil in chronic hepatitis B patients with lamivudine resistance

PURPOSE: We and others have reported that adding adefovir dipivoxil (adefovir) to lamivudine results in virological and biochemical improvement in cases of lamivudine resistance. The current study assessed the efficacy and safety of combined therapy after 104 weeks of combined treatment and analyzed...

Full description

Saved in:
Bibliographic Details
Main Authors: Perrillo, Robert P., Hann, Hie-Won, Schiff, Eugene, Mutimer, David, Willems, Bernard, Leung, Nancy, Lee, William M., Dixon, Susan, Woessner, Mary, Brosgart, Carol L., Condreay, Lynn D., Gardner, Stephen D.
Format: Artigo
Language:Inglês
Published: Springer-Verlag 2011
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3090563/
https://ncbi.nlm.nih.gov/pubmed/21484148
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12072-010-9228-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items